nodes	percent_of_prediction	percent_of_DWPC	metapath
Aciclovir—SLC22A1—prostate cancer	0.309	1	CbGaD
Aciclovir—SLC47A2—Mitoxantrone—prostate cancer	0.253	0.545	CbGbCtD
Aciclovir—SLC47A1—Mitoxantrone—prostate cancer	0.105	0.226	CbGbCtD
Aciclovir—SLC22A8—Conjugated Estrogens—prostate cancer	0.0306	0.0661	CbGbCtD
Aciclovir—SLC22A1—Estradiol—prostate cancer	0.0272	0.0587	CbGbCtD
Aciclovir—SLC22A8—Estradiol—prostate cancer	0.0269	0.058	CbGbCtD
Aciclovir—SLC22A6—Conjugated Estrogens—prostate cancer	0.0213	0.046	CbGbCtD
Aciclovir—SLC22A8—urine—prostate cancer	0.00295	0.182	CbGeAlD
Aciclovir—SLC47A2—renal system—prostate cancer	0.00269	0.165	CbGeAlD
Aciclovir—SLC10A2—renal system—prostate cancer	0.00259	0.159	CbGeAlD
Aciclovir—SLC47A1—prostate gland—prostate cancer	0.00138	0.0849	CbGeAlD
Aciclovir—SLC47A1—seminal vesicle—prostate cancer	0.00117	0.0718	CbGeAlD
Aciclovir—SLC22A8—prostate gland—prostate cancer	0.00106	0.0652	CbGeAlD
Aciclovir—SLC47A1—renal system—prostate cancer	0.000941	0.0579	CbGeAlD
Aciclovir—SLC47A1—urethra—prostate cancer	0.000924	0.0569	CbGeAlD
Aciclovir—Ganciclovir—SLC22A1—prostate cancer	0.000868	1	CrCbGaD
Aciclovir—SLC22A1—renal system—prostate cancer	0.000785	0.0483	CbGeAlD
Aciclovir—SLC22A8—renal system—prostate cancer	0.000722	0.0444	CbGeAlD
Aciclovir—SLC47A1—testis—prostate cancer	0.000608	0.0374	CbGeAlD
Aciclovir—SLC47A1—lymph node—prostate cancer	0.000441	0.0271	CbGeAlD
Aciclovir—SLC10A2—Metabolism—UCP3—prostate cancer	6.35e-05	0.00122	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—TCN2—prostate cancer	6.35e-05	0.00122	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GSTA3—prostate cancer	6.35e-05	0.00122	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—RRAS—prostate cancer	6.28e-05	0.0012	CbGpPWpGaD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—PLCB2—prostate cancer	6.22e-05	0.00119	CbGpPWpGaD
Aciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	6.19e-05	0.00118	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	6.11e-05	0.00117	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—SLC22A3—prostate cancer	6.06e-05	0.00116	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—HSD3B1—prostate cancer	6.06e-05	0.00116	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC39A1—prostate cancer	5.98e-05	0.00115	CbGpPWpGaD
Aciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	5.9e-05	0.00113	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	5.88e-05	0.00113	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	5.88e-05	0.00113	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—CYP7B1—prostate cancer	5.85e-05	0.00112	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	5.83e-05	0.00112	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GSTA4—prostate cancer	5.81e-05	0.00111	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—TBXAS1—prostate cancer	5.81e-05	0.00111	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—PPARA—prostate cancer	5.81e-05	0.00111	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SLC12A2—prostate cancer	5.7e-05	0.00109	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SLC26A4—prostate cancer	5.7e-05	0.00109	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	5.68e-05	0.00109	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GSTA2—prostate cancer	5.66e-05	0.00108	CbGpPWpGaD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—GNG5—prostate cancer	5.64e-05	0.00108	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—SULT1A1—prostate cancer	5.59e-05	0.00107	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ABCG5—prostate cancer	5.59e-05	0.00107	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GSTA1—prostate cancer	5.46e-05	0.00105	CbGpPWpGaD
Aciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	5.41e-05	0.00104	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GSTO1—prostate cancer	5.4e-05	0.00103	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—HSD3B2—prostate cancer	5.4e-05	0.00103	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—NAT2—prostate cancer	5.4e-05	0.00103	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	5.19e-05	0.000995	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PLCB2—prostate cancer	5.18e-05	0.000992	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CYP2C18—prostate cancer	5.18e-05	0.000992	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—LRP2—prostate cancer	5.18e-05	0.000992	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	5.15e-05	0.000986	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—P4HB—prostate cancer	5.08e-05	0.000973	CbGpPWpGaD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—ACHE—prostate cancer	5.03e-05	0.000963	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—SLC22A1—prostate cancer	4.94e-05	0.000946	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—PPARA—prostate cancer	4.94e-05	0.000946	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—RXRA—prostate cancer	4.9e-05	0.000938	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	4.88e-05	0.000935	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—CYP7B1—prostate cancer	4.88e-05	0.000934	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—SULT2A1—prostate cancer	4.81e-05	0.000922	CbGpPWpGaD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—PRKACB—prostate cancer	4.81e-05	0.000921	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—PLCB2—prostate cancer	4.76e-05	0.000912	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC12A2—prostate cancer	4.75e-05	0.00091	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC26A4—prostate cancer	4.75e-05	0.00091	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—MED12—prostate cancer	4.74e-05	0.000907	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GNG5—prostate cancer	4.7e-05	0.0009	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	4.65e-05	0.00089	CbGpPWpGaD
Aciclovir—Oedema—Capecitabine—prostate cancer	4.63e-05	0.000292	CcSEcCtD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A3—prostate cancer	4.62e-05	0.000885	CbGpPWpGaD
Aciclovir—Angioedema—Prednisone—prostate cancer	4.62e-05	0.000292	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	4.61e-05	0.000883	CbGpPWpGaD
Aciclovir—Renal failure—Doxorubicin—prostate cancer	4.6e-05	0.000291	CcSEcCtD
Aciclovir—Urticaria—Etoposide—prostate cancer	4.57e-05	0.000289	CcSEcCtD
Aciclovir—Jaundice—Doxorubicin—prostate cancer	4.56e-05	0.000288	CcSEcCtD
Aciclovir—Anorexia—Docetaxel—prostate cancer	4.56e-05	0.000288	CcSEcCtD
Aciclovir—Malaise—Prednisone—prostate cancer	4.56e-05	0.000288	CcSEcCtD
Aciclovir—Abdominal pain—Etoposide—prostate cancer	4.55e-05	0.000287	CcSEcCtD
Aciclovir—Body temperature increased—Etoposide—prostate cancer	4.55e-05	0.000287	CcSEcCtD
Aciclovir—Conjunctivitis—Doxorubicin—prostate cancer	4.55e-05	0.000287	CcSEcCtD
Aciclovir—Nervous system disorder—Capecitabine—prostate cancer	4.54e-05	0.000287	CcSEcCtD
Aciclovir—Vertigo—Prednisone—prostate cancer	4.54e-05	0.000287	CcSEcCtD
Aciclovir—Hepatitis—Epirubicin—prostate cancer	4.54e-05	0.000287	CcSEcCtD
Aciclovir—Thrombocytopenia—Capecitabine—prostate cancer	4.53e-05	0.000286	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—NCOA3—prostate cancer	4.53e-05	0.000867	CbGpPWpGaD
Aciclovir—Tachycardia—Capecitabine—prostate cancer	4.52e-05	0.000285	CcSEcCtD
Aciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	4.51e-05	0.000864	CbGpPWpGaD
Aciclovir—Skin disorder—Capecitabine—prostate cancer	4.5e-05	0.000284	CcSEcCtD
Aciclovir—Urinary tract disorder—Epirubicin—prostate cancer	4.48e-05	0.000283	CcSEcCtD
Aciclovir—Hyperhidrosis—Capecitabine—prostate cancer	4.48e-05	0.000283	CcSEcCtD
Aciclovir—Oedema peripheral—Epirubicin—prostate cancer	4.47e-05	0.000283	CcSEcCtD
Aciclovir—Hypotension—Docetaxel—prostate cancer	4.47e-05	0.000282	CcSEcCtD
Aciclovir—Haematuria—Doxorubicin—prostate cancer	4.46e-05	0.000282	CcSEcCtD
Aciclovir—Urethral disorder—Epirubicin—prostate cancer	4.45e-05	0.000281	CcSEcCtD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	4.45e-05	0.000852	CbGpPWpGaD
Aciclovir—Hepatobiliary disease—Doxorubicin—prostate cancer	4.43e-05	0.00028	CcSEcCtD
Aciclovir—Anorexia—Capecitabine—prostate cancer	4.41e-05	0.000279	CcSEcCtD
Aciclovir—Nausea—Estradiol—prostate cancer	4.41e-05	0.000279	CcSEcCtD
Aciclovir—Vomiting—Mitoxantrone—prostate cancer	4.4e-05	0.000278	CcSEcCtD
Aciclovir—Convulsion—Prednisone—prostate cancer	4.38e-05	0.000277	CcSEcCtD
Aciclovir—Hypertension—Prednisone—prostate cancer	4.36e-05	0.000276	CcSEcCtD
Aciclovir—Rash—Mitoxantrone—prostate cancer	4.36e-05	0.000276	CcSEcCtD
Aciclovir—Dermatitis—Mitoxantrone—prostate cancer	4.36e-05	0.000275	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.36e-05	0.000275	CcSEcCtD
Aciclovir—Headache—Mitoxantrone—prostate cancer	4.33e-05	0.000274	CcSEcCtD
Aciclovir—Hypotension—Capecitabine—prostate cancer	4.33e-05	0.000273	CcSEcCtD
Aciclovir—Insomnia—Docetaxel—prostate cancer	4.33e-05	0.000273	CcSEcCtD
Aciclovir—SLC22A1—Neuronal System—GNG5—prostate cancer	4.32e-05	0.000828	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—HPGDS—prostate cancer	4.32e-05	0.000827	CbGpPWpGaD
Aciclovir—Myalgia—Prednisone—prostate cancer	4.3e-05	0.000272	CcSEcCtD
Aciclovir—Arthralgia—Prednisone—prostate cancer	4.3e-05	0.000272	CcSEcCtD
Aciclovir—Paraesthesia—Docetaxel—prostate cancer	4.29e-05	0.000271	CcSEcCtD
Aciclovir—Erythema multiforme—Epirubicin—prostate cancer	4.29e-05	0.000271	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—CYP2C19—prostate cancer	4.29e-05	0.000822	CbGpPWpGaD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	4.27e-05	0.00027	CcSEcCtD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—ABCG5—prostate cancer	4.26e-05	0.000817	CbGpPWpGaD
Aciclovir—Dyspnoea—Docetaxel—prostate cancer	4.26e-05	0.000269	CcSEcCtD
Aciclovir—Somnolence—Docetaxel—prostate cancer	4.25e-05	0.000269	CcSEcCtD
Aciclovir—Discomfort—Prednisone—prostate cancer	4.25e-05	0.000268	CcSEcCtD
Aciclovir—Eye disorder—Epirubicin—prostate cancer	4.24e-05	0.000268	CcSEcCtD
Aciclovir—Hypersensitivity—Etoposide—prostate cancer	4.24e-05	0.000268	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.22e-05	0.000266	CcSEcCtD
Aciclovir—Dyspepsia—Docetaxel—prostate cancer	4.21e-05	0.000266	CcSEcCtD
Aciclovir—Hepatitis—Doxorubicin—prostate cancer	4.2e-05	0.000265	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—GSTT1—prostate cancer	4.19e-05	0.000802	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ACHE—prostate cancer	4.19e-05	0.000802	CbGpPWpGaD
Aciclovir—Insomnia—Capecitabine—prostate cancer	4.19e-05	0.000265	CcSEcCtD
Aciclovir—Paraesthesia—Capecitabine—prostate cancer	4.16e-05	0.000263	CcSEcCtD
Aciclovir—Decreased appetite—Docetaxel—prostate cancer	4.16e-05	0.000263	CcSEcCtD
Aciclovir—Urinary tract disorder—Doxorubicin—prostate cancer	4.15e-05	0.000262	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—CYP2A6—prostate cancer	4.14e-05	0.000793	CbGpPWpGaD
Aciclovir—Oedema peripheral—Doxorubicin—prostate cancer	4.14e-05	0.000261	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Docetaxel—prostate cancer	4.13e-05	0.000261	CcSEcCtD
Aciclovir—Asthenia—Etoposide—prostate cancer	4.13e-05	0.000261	CcSEcCtD
Aciclovir—Dyspnoea—Capecitabine—prostate cancer	4.13e-05	0.000261	CcSEcCtD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	4.12e-05	0.00079	CbGpPWpGaD
Aciclovir—Oedema—Prednisone—prostate cancer	4.12e-05	0.000261	CcSEcCtD
Aciclovir—Anaphylactic shock—Prednisone—prostate cancer	4.12e-05	0.000261	CcSEcCtD
Aciclovir—Fatigue—Docetaxel—prostate cancer	4.12e-05	0.00026	CcSEcCtD
Aciclovir—Urethral disorder—Doxorubicin—prostate cancer	4.12e-05	0.00026	CcSEcCtD
Aciclovir—Nausea—Mitoxantrone—prostate cancer	4.11e-05	0.00026	CcSEcCtD
Aciclovir—Immune system disorder—Epirubicin—prostate cancer	4.1e-05	0.000259	CcSEcCtD
Aciclovir—Mediastinal disorder—Epirubicin—prostate cancer	4.09e-05	0.000258	CcSEcCtD
Aciclovir—Pain—Docetaxel—prostate cancer	4.09e-05	0.000258	CcSEcCtD
Aciclovir—Constipation—Docetaxel—prostate cancer	4.09e-05	0.000258	CcSEcCtD
Aciclovir—Dyspepsia—Capecitabine—prostate cancer	4.08e-05	0.000257	CcSEcCtD
Aciclovir—Chills—Epirubicin—prostate cancer	4.07e-05	0.000257	CcSEcCtD
Aciclovir—Pruritus—Etoposide—prostate cancer	4.07e-05	0.000257	CcSEcCtD
Aciclovir—Nervous system disorder—Prednisone—prostate cancer	4.04e-05	0.000255	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—AKR1C3—prostate cancer	4.03e-05	0.000771	CbGpPWpGaD
Aciclovir—Tachycardia—Prednisone—prostate cancer	4.03e-05	0.000254	CcSEcCtD
Aciclovir—Decreased appetite—Capecitabine—prostate cancer	4.02e-05	0.000254	CcSEcCtD
Aciclovir—Alopecia—Epirubicin—prostate cancer	4.01e-05	0.000253	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—PRKACB—prostate cancer	4.01e-05	0.000767	CbGpPWpGaD
Aciclovir—Skin disorder—Prednisone—prostate cancer	4.01e-05	0.000253	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Capecitabine—prostate cancer	4e-05	0.000252	CcSEcCtD
Aciclovir—Fatigue—Capecitabine—prostate cancer	3.99e-05	0.000252	CcSEcCtD
Aciclovir—Hyperhidrosis—Prednisone—prostate cancer	3.99e-05	0.000252	CcSEcCtD
Aciclovir—Erythema multiforme—Doxorubicin—prostate cancer	3.97e-05	0.000251	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—CYP17A1—prostate cancer	3.97e-05	0.000759	CbGpPWpGaD
Aciclovir—Pain—Capecitabine—prostate cancer	3.96e-05	0.00025	CcSEcCtD
Aciclovir—Constipation—Capecitabine—prostate cancer	3.96e-05	0.00025	CcSEcCtD
Aciclovir—Erythema—Epirubicin—prostate cancer	3.95e-05	0.00025	CcSEcCtD
Aciclovir—Feeling abnormal—Docetaxel—prostate cancer	3.94e-05	0.000249	CcSEcCtD
Aciclovir—Diarrhoea—Etoposide—prostate cancer	3.94e-05	0.000249	CcSEcCtD
Aciclovir—Anorexia—Prednisone—prostate cancer	3.93e-05	0.000248	CcSEcCtD
Aciclovir—Eye disorder—Doxorubicin—prostate cancer	3.93e-05	0.000248	CcSEcCtD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.92e-05	0.000751	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.91e-05	0.000749	CbGpPWpGaD
Aciclovir—Gastrointestinal pain—Docetaxel—prostate cancer	3.91e-05	0.000247	CcSEcCtD
Aciclovir—Flatulence—Epirubicin—prostate cancer	3.89e-05	0.000246	CcSEcCtD
Aciclovir—Dysgeusia—Epirubicin—prostate cancer	3.87e-05	0.000244	CcSEcCtD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A3—prostate cancer	3.86e-05	0.000738	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—ACHE—prostate cancer	3.85e-05	0.000738	CbGpPWpGaD
Aciclovir—Feeling abnormal—Capecitabine—prostate cancer	3.82e-05	0.000241	CcSEcCtD
Aciclovir—Dizziness—Etoposide—prostate cancer	3.81e-05	0.00024	CcSEcCtD
Aciclovir—Muscle spasms—Epirubicin—prostate cancer	3.8e-05	0.00024	CcSEcCtD
Aciclovir—Immune system disorder—Doxorubicin—prostate cancer	3.79e-05	0.00024	CcSEcCtD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	3.79e-05	0.000726	CbGpPWpGaD
Aciclovir—Gastrointestinal pain—Capecitabine—prostate cancer	3.79e-05	0.000239	CcSEcCtD
Aciclovir—Mediastinal disorder—Doxorubicin—prostate cancer	3.79e-05	0.000239	CcSEcCtD
Aciclovir—Abdominal pain—Docetaxel—prostate cancer	3.78e-05	0.000239	CcSEcCtD
Aciclovir—Body temperature increased—Docetaxel—prostate cancer	3.78e-05	0.000239	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—NCOA2—prostate cancer	3.78e-05	0.000723	CbGpPWpGaD
Aciclovir—Chills—Doxorubicin—prostate cancer	3.77e-05	0.000238	CcSEcCtD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A1—prostate cancer	3.77e-05	0.000721	CbGpPWpGaD
Aciclovir—Musculoskeletal discomfort—Prednisone—prostate cancer	3.76e-05	0.000237	CcSEcCtD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—PPARA—prostate cancer	3.74e-05	0.000717	CbGpPWpGaD
Aciclovir—Insomnia—Prednisone—prostate cancer	3.73e-05	0.000236	CcSEcCtD
Aciclovir—Alopecia—Doxorubicin—prostate cancer	3.71e-05	0.000234	CcSEcCtD
Aciclovir—Paraesthesia—Prednisone—prostate cancer	3.7e-05	0.000234	CcSEcCtD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	3.69e-05	0.000707	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	3.69e-05	0.000707	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—PRKACB—prostate cancer	3.68e-05	0.000705	CbGpPWpGaD
Aciclovir—Urticaria—Capecitabine—prostate cancer	3.68e-05	0.000232	CcSEcCtD
Aciclovir—Ill-defined disorder—Epirubicin—prostate cancer	3.67e-05	0.000232	CcSEcCtD
Aciclovir—Body temperature increased—Capecitabine—prostate cancer	3.66e-05	0.000231	CcSEcCtD
Aciclovir—Abdominal pain—Capecitabine—prostate cancer	3.66e-05	0.000231	CcSEcCtD
Aciclovir—Vomiting—Etoposide—prostate cancer	3.66e-05	0.000231	CcSEcCtD
Aciclovir—Erythema—Doxorubicin—prostate cancer	3.66e-05	0.000231	CcSEcCtD
Aciclovir—Anaemia—Epirubicin—prostate cancer	3.65e-05	0.000231	CcSEcCtD
Aciclovir—Agitation—Epirubicin—prostate cancer	3.63e-05	0.000229	CcSEcCtD
Aciclovir—Dyspepsia—Prednisone—prostate cancer	3.63e-05	0.000229	CcSEcCtD
Aciclovir—Rash—Etoposide—prostate cancer	3.63e-05	0.000229	CcSEcCtD
Aciclovir—Dermatitis—Etoposide—prostate cancer	3.62e-05	0.000229	CcSEcCtD
Aciclovir—Headache—Etoposide—prostate cancer	3.6e-05	0.000228	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—SLC5A5—prostate cancer	3.6e-05	0.00069	CbGpPWpGaD
Aciclovir—Flatulence—Doxorubicin—prostate cancer	3.6e-05	0.000228	CcSEcCtD
Aciclovir—Decreased appetite—Prednisone—prostate cancer	3.59e-05	0.000226	CcSEcCtD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—GNG5—prostate cancer	3.58e-05	0.000686	CbGpPWpGaD
Aciclovir—Dysgeusia—Doxorubicin—prostate cancer	3.58e-05	0.000226	CcSEcCtD
Aciclovir—Malaise—Epirubicin—prostate cancer	3.56e-05	0.000225	CcSEcCtD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—ABCG5—prostate cancer	3.56e-05	0.000681	CbGpPWpGaD
Aciclovir—Fatigue—Prednisone—prostate cancer	3.56e-05	0.000225	CcSEcCtD
Aciclovir—Vertigo—Epirubicin—prostate cancer	3.55e-05	0.000224	CcSEcCtD
Aciclovir—Leukopenia—Epirubicin—prostate cancer	3.54e-05	0.000223	CcSEcCtD
Aciclovir—Constipation—Prednisone—prostate cancer	3.53e-05	0.000223	CcSEcCtD
Aciclovir—Hypersensitivity—Docetaxel—prostate cancer	3.52e-05	0.000223	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—CYP2E1—prostate cancer	3.52e-05	0.000674	CbGpPWpGaD
Aciclovir—Muscle spasms—Doxorubicin—prostate cancer	3.52e-05	0.000222	CcSEcCtD
Aciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	3.51e-05	0.000672	CbGpPWpGaD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—COMT—prostate cancer	3.5e-05	0.00067	CbGpPWpGaD
Aciclovir—Palpitations—Epirubicin—prostate cancer	3.49e-05	0.000221	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—NQO1—prostate cancer	3.48e-05	0.000667	CbGpPWpGaD
Aciclovir—Asthenia—Docetaxel—prostate cancer	3.43e-05	0.000217	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—TH—prostate cancer	3.43e-05	0.000657	CbGpPWpGaD
Aciclovir—Convulsion—Epirubicin—prostate cancer	3.42e-05	0.000216	CcSEcCtD
Aciclovir—Nausea—Etoposide—prostate cancer	3.42e-05	0.000216	CcSEcCtD
Aciclovir—Hypertension—Epirubicin—prostate cancer	3.41e-05	0.000216	CcSEcCtD
Aciclovir—Hypersensitivity—Capecitabine—prostate cancer	3.41e-05	0.000215	CcSEcCtD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.41e-05	0.000653	CbGpPWpGaD
Aciclovir—Feeling abnormal—Prednisone—prostate cancer	3.4e-05	0.000215	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—CYP3A4—prostate cancer	3.39e-05	0.00065	CbGpPWpGaD
Aciclovir—Ill-defined disorder—Doxorubicin—prostate cancer	3.39e-05	0.000214	CcSEcCtD
Aciclovir—Pruritus—Docetaxel—prostate cancer	3.38e-05	0.000214	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—HAO1—prostate cancer	3.38e-05	0.000647	CbGpPWpGaD
Aciclovir—Anaemia—Doxorubicin—prostate cancer	3.38e-05	0.000213	CcSEcCtD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.38e-05	0.000647	CbGpPWpGaD
Aciclovir—Gastrointestinal pain—Prednisone—prostate cancer	3.37e-05	0.000213	CcSEcCtD
Aciclovir—Myalgia—Epirubicin—prostate cancer	3.36e-05	0.000213	CcSEcCtD
Aciclovir—Chest pain—Epirubicin—prostate cancer	3.36e-05	0.000213	CcSEcCtD
Aciclovir—Arthralgia—Epirubicin—prostate cancer	3.36e-05	0.000213	CcSEcCtD
Aciclovir—Agitation—Doxorubicin—prostate cancer	3.36e-05	0.000212	CcSEcCtD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	3.34e-05	0.000211	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—CYP1B1—prostate cancer	3.34e-05	0.000639	CbGpPWpGaD
Aciclovir—Discomfort—Epirubicin—prostate cancer	3.32e-05	0.00021	CcSEcCtD
Aciclovir—Asthenia—Capecitabine—prostate cancer	3.32e-05	0.00021	CcSEcCtD
Aciclovir—Malaise—Doxorubicin—prostate cancer	3.3e-05	0.000208	CcSEcCtD
Aciclovir—Vertigo—Doxorubicin—prostate cancer	3.29e-05	0.000208	CcSEcCtD
Aciclovir—Urticaria—Prednisone—prostate cancer	3.28e-05	0.000207	CcSEcCtD
Aciclovir—Pruritus—Capecitabine—prostate cancer	3.28e-05	0.000207	CcSEcCtD
Aciclovir—Leukopenia—Doxorubicin—prostate cancer	3.27e-05	0.000207	CcSEcCtD
Aciclovir—Diarrhoea—Docetaxel—prostate cancer	3.27e-05	0.000207	CcSEcCtD
Aciclovir—Abdominal pain—Prednisone—prostate cancer	3.26e-05	0.000206	CcSEcCtD
Aciclovir—Body temperature increased—Prednisone—prostate cancer	3.26e-05	0.000206	CcSEcCtD
Aciclovir—Confusional state—Epirubicin—prostate cancer	3.25e-05	0.000205	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—GGT1—prostate cancer	3.23e-05	0.000619	CbGpPWpGaD
Aciclovir—Palpitations—Doxorubicin—prostate cancer	3.23e-05	0.000204	CcSEcCtD
Aciclovir—Oedema—Epirubicin—prostate cancer	3.23e-05	0.000204	CcSEcCtD
Aciclovir—Anaphylactic shock—Epirubicin—prostate cancer	3.23e-05	0.000204	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—NCOA1—prostate cancer	3.18e-05	0.00061	CbGpPWpGaD
Aciclovir—Convulsion—Doxorubicin—prostate cancer	3.17e-05	0.0002	CcSEcCtD
Aciclovir—Diarrhoea—Capecitabine—prostate cancer	3.17e-05	0.0002	CcSEcCtD
Aciclovir—Nervous system disorder—Epirubicin—prostate cancer	3.16e-05	0.0002	CcSEcCtD
Aciclovir—Dizziness—Docetaxel—prostate cancer	3.16e-05	0.0002	CcSEcCtD
Aciclovir—Thrombocytopenia—Epirubicin—prostate cancer	3.16e-05	0.000199	CcSEcCtD
Aciclovir—Hypertension—Doxorubicin—prostate cancer	3.16e-05	0.000199	CcSEcCtD
Aciclovir—Tachycardia—Epirubicin—prostate cancer	3.15e-05	0.000199	CcSEcCtD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A1—prostate cancer	3.14e-05	0.000602	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CYP19A1—prostate cancer	3.14e-05	0.000601	CbGpPWpGaD
Aciclovir—Skin disorder—Epirubicin—prostate cancer	3.13e-05	0.000198	CcSEcCtD
Aciclovir—Hyperhidrosis—Epirubicin—prostate cancer	3.12e-05	0.000197	CcSEcCtD
Aciclovir—Arthralgia—Doxorubicin—prostate cancer	3.11e-05	0.000197	CcSEcCtD
Aciclovir—Myalgia—Doxorubicin—prostate cancer	3.11e-05	0.000197	CcSEcCtD
Aciclovir—Chest pain—Doxorubicin—prostate cancer	3.11e-05	0.000197	CcSEcCtD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.09e-05	0.000195	CcSEcCtD
Aciclovir—Discomfort—Doxorubicin—prostate cancer	3.08e-05	0.000194	CcSEcCtD
Aciclovir—Anorexia—Epirubicin—prostate cancer	3.07e-05	0.000194	CcSEcCtD
Aciclovir—Dizziness—Capecitabine—prostate cancer	3.06e-05	0.000193	CcSEcCtD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—PRKACB—prostate cancer	3.05e-05	0.000585	CbGpPWpGaD
Aciclovir—Vomiting—Docetaxel—prostate cancer	3.04e-05	0.000192	CcSEcCtD
Aciclovir—Hypersensitivity—Prednisone—prostate cancer	3.04e-05	0.000192	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—RXRA—prostate cancer	3.03e-05	0.00058	CbGpPWpGaD
Aciclovir—Rash—Docetaxel—prostate cancer	3.02e-05	0.00019	CcSEcCtD
Aciclovir—Hypotension—Epirubicin—prostate cancer	3.01e-05	0.00019	CcSEcCtD
Aciclovir—Dermatitis—Docetaxel—prostate cancer	3.01e-05	0.00019	CcSEcCtD
Aciclovir—Confusional state—Doxorubicin—prostate cancer	3.01e-05	0.00019	CcSEcCtD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	3e-05	0.000574	CbGpPWpGaD
Aciclovir—Headache—Docetaxel—prostate cancer	3e-05	0.000189	CcSEcCtD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—GNG5—prostate cancer	2.99e-05	0.000573	CbGpPWpGaD
Aciclovir—Anaphylactic shock—Doxorubicin—prostate cancer	2.98e-05	0.000189	CcSEcCtD
Aciclovir—Oedema—Doxorubicin—prostate cancer	2.98e-05	0.000189	CcSEcCtD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.97e-05	0.000569	CbGpPWpGaD
Aciclovir—Asthenia—Prednisone—prostate cancer	2.96e-05	0.000187	CcSEcCtD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.95e-05	0.000564	CbGpPWpGaD
Aciclovir—Vomiting—Capecitabine—prostate cancer	2.94e-05	0.000186	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.94e-05	0.000186	CcSEcCtD
Aciclovir—Nervous system disorder—Doxorubicin—prostate cancer	2.93e-05	0.000185	CcSEcCtD
Aciclovir—Thrombocytopenia—Doxorubicin—prostate cancer	2.92e-05	0.000185	CcSEcCtD
Aciclovir—Rash—Capecitabine—prostate cancer	2.92e-05	0.000184	CcSEcCtD
Aciclovir—Pruritus—Prednisone—prostate cancer	2.92e-05	0.000184	CcSEcCtD
Aciclovir—Insomnia—Epirubicin—prostate cancer	2.92e-05	0.000184	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—COMT—prostate cancer	2.92e-05	0.000559	CbGpPWpGaD
Aciclovir—Dermatitis—Capecitabine—prostate cancer	2.92e-05	0.000184	CcSEcCtD
Aciclovir—Tachycardia—Doxorubicin—prostate cancer	2.91e-05	0.000184	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—GSTP1—prostate cancer	2.9e-05	0.000556	CbGpPWpGaD
Aciclovir—Headache—Capecitabine—prostate cancer	2.9e-05	0.000183	CcSEcCtD
Aciclovir—Skin disorder—Doxorubicin—prostate cancer	2.9e-05	0.000183	CcSEcCtD
Aciclovir—Paraesthesia—Epirubicin—prostate cancer	2.9e-05	0.000183	CcSEcCtD
Aciclovir—Hyperhidrosis—Doxorubicin—prostate cancer	2.89e-05	0.000182	CcSEcCtD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—NCOA2—prostate cancer	2.88e-05	0.000552	CbGpPWpGaD
Aciclovir—Dyspnoea—Epirubicin—prostate cancer	2.88e-05	0.000182	CcSEcCtD
Aciclovir—Somnolence—Epirubicin—prostate cancer	2.87e-05	0.000181	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—ITPR1—prostate cancer	2.86e-05	0.000547	CbGpPWpGaD
Aciclovir—Anorexia—Doxorubicin—prostate cancer	2.84e-05	0.00018	CcSEcCtD
Aciclovir—Nausea—Docetaxel—prostate cancer	2.84e-05	0.000179	CcSEcCtD
Aciclovir—Dyspepsia—Epirubicin—prostate cancer	2.84e-05	0.000179	CcSEcCtD
Aciclovir—Diarrhoea—Prednisone—prostate cancer	2.82e-05	0.000178	CcSEcCtD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.81e-05	0.000538	CbGpPWpGaD
Aciclovir—Decreased appetite—Epirubicin—prostate cancer	2.8e-05	0.000177	CcSEcCtD
Aciclovir—Hypotension—Doxorubicin—prostate cancer	2.79e-05	0.000176	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Epirubicin—prostate cancer	2.78e-05	0.000176	CcSEcCtD
Aciclovir—Fatigue—Epirubicin—prostate cancer	2.78e-05	0.000176	CcSEcCtD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—ABCG5—prostate cancer	2.77e-05	0.00053	CbGpPWpGaD
Aciclovir—Constipation—Epirubicin—prostate cancer	2.76e-05	0.000174	CcSEcCtD
Aciclovir—Pain—Epirubicin—prostate cancer	2.76e-05	0.000174	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—CSAD—prostate cancer	2.76e-05	0.000528	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PSAT1—prostate cancer	2.76e-05	0.000528	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CBR1—prostate cancer	2.76e-05	0.000528	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ADI1—prostate cancer	2.76e-05	0.000528	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—TST—prostate cancer	2.76e-05	0.000528	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GRHL1—prostate cancer	2.76e-05	0.000528	CbGpPWpGaD
Aciclovir—Nausea—Capecitabine—prostate cancer	2.75e-05	0.000174	CcSEcCtD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SLC5A5—prostate cancer	2.75e-05	0.000526	CbGpPWpGaD
Aciclovir—Dizziness—Prednisone—prostate cancer	2.73e-05	0.000172	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.72e-05	0.000172	CcSEcCtD
Aciclovir—Insomnia—Doxorubicin—prostate cancer	2.7e-05	0.000171	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—TYMS—prostate cancer	2.7e-05	0.000517	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—COMT—prostate cancer	2.68e-05	0.000514	CbGpPWpGaD
Aciclovir—Paraesthesia—Doxorubicin—prostate cancer	2.68e-05	0.000169	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—GSTM1—prostate cancer	2.67e-05	0.000511	CbGpPWpGaD
Aciclovir—Dyspnoea—Doxorubicin—prostate cancer	2.66e-05	0.000168	CcSEcCtD
Aciclovir—Feeling abnormal—Epirubicin—prostate cancer	2.66e-05	0.000168	CcSEcCtD
Aciclovir—Somnolence—Doxorubicin—prostate cancer	2.65e-05	0.000168	CcSEcCtD
Aciclovir—Gastrointestinal pain—Epirubicin—prostate cancer	2.64e-05	0.000167	CcSEcCtD
Aciclovir—Dyspepsia—Doxorubicin—prostate cancer	2.63e-05	0.000166	CcSEcCtD
Aciclovir—Vomiting—Prednisone—prostate cancer	2.62e-05	0.000166	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—LPL—prostate cancer	2.62e-05	0.000501	CbGpPWpGaD
Aciclovir—Rash—Prednisone—prostate cancer	2.6e-05	0.000164	CcSEcCtD
Aciclovir—Dermatitis—Prednisone—prostate cancer	2.6e-05	0.000164	CcSEcCtD
Aciclovir—Decreased appetite—Doxorubicin—prostate cancer	2.59e-05	0.000164	CcSEcCtD
Aciclovir—Headache—Prednisone—prostate cancer	2.58e-05	0.000163	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.58e-05	0.000163	CcSEcCtD
Aciclovir—Fatigue—Doxorubicin—prostate cancer	2.57e-05	0.000163	CcSEcCtD
Aciclovir—Urticaria—Epirubicin—prostate cancer	2.56e-05	0.000162	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—UGT2B17—prostate cancer	2.56e-05	0.00049	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CKMT2—prostate cancer	2.56e-05	0.00049	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GRHPR—prostate cancer	2.56e-05	0.00049	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—UGT2B15—prostate cancer	2.56e-05	0.00049	CbGpPWpGaD
Aciclovir—Constipation—Doxorubicin—prostate cancer	2.55e-05	0.000161	CcSEcCtD
Aciclovir—Pain—Doxorubicin—prostate cancer	2.55e-05	0.000161	CcSEcCtD
Aciclovir—Abdominal pain—Epirubicin—prostate cancer	2.55e-05	0.000161	CcSEcCtD
Aciclovir—Body temperature increased—Epirubicin—prostate cancer	2.55e-05	0.000161	CcSEcCtD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—PRKACB—prostate cancer	2.55e-05	0.000488	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CYP1A1—prostate cancer	2.53e-05	0.000484	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ERCC2—prostate cancer	2.51e-05	0.00048	CbGpPWpGaD
Aciclovir—Feeling abnormal—Doxorubicin—prostate cancer	2.46e-05	0.000155	CcSEcCtD
Aciclovir—Nausea—Prednisone—prostate cancer	2.45e-05	0.000155	CcSEcCtD
Aciclovir—Gastrointestinal pain—Doxorubicin—prostate cancer	2.44e-05	0.000154	CcSEcCtD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.43e-05	0.000465	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—MBTPS1—prostate cancer	2.41e-05	0.000461	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—SULT2B1—prostate cancer	2.41e-05	0.000461	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PGAM2—prostate cancer	2.41e-05	0.000461	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—NAGLU—prostate cancer	2.41e-05	0.000461	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—AOX1—prostate cancer	2.41e-05	0.000461	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—RFK—prostate cancer	2.41e-05	0.000461	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTM3—prostate cancer	2.41e-05	0.000461	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—NCOA2—prostate cancer	2.4e-05	0.00046	CbGpPWpGaD
Aciclovir—Hypersensitivity—Epirubicin—prostate cancer	2.38e-05	0.00015	CcSEcCtD
Aciclovir—Urticaria—Doxorubicin—prostate cancer	2.37e-05	0.00015	CcSEcCtD
Aciclovir—Body temperature increased—Doxorubicin—prostate cancer	2.36e-05	0.000149	CcSEcCtD
Aciclovir—Abdominal pain—Doxorubicin—prostate cancer	2.36e-05	0.000149	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—MTHFR—prostate cancer	2.36e-05	0.000451	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—GNG5—prostate cancer	2.32e-05	0.000445	CbGpPWpGaD
Aciclovir—Asthenia—Epirubicin—prostate cancer	2.31e-05	0.000146	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—PPARA—prostate cancer	2.31e-05	0.000443	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—RXRA—prostate cancer	2.31e-05	0.000442	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	2.29e-05	0.000439	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP3A43—prostate cancer	2.28e-05	0.000437	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—AMACR—prostate cancer	2.28e-05	0.000437	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—NAT1—prostate cancer	2.28e-05	0.000437	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—SRD5A2—prostate cancer	2.28e-05	0.000437	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—DEGS1—prostate cancer	2.28e-05	0.000437	CbGpPWpGaD
Aciclovir—Pruritus—Epirubicin—prostate cancer	2.28e-05	0.000144	CcSEcCtD
Aciclovir—Diarrhoea—Epirubicin—prostate cancer	2.21e-05	0.000139	CcSEcCtD
Aciclovir—Hypersensitivity—Doxorubicin—prostate cancer	2.2e-05	0.000139	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—HSD17B1—prostate cancer	2.18e-05	0.000417	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CAV1—prostate cancer	2.18e-05	0.000416	CbGpPWpGaD
Aciclovir—Asthenia—Doxorubicin—prostate cancer	2.14e-05	0.000135	CcSEcCtD
Aciclovir—Dizziness—Epirubicin—prostate cancer	2.13e-05	0.000135	CcSEcCtD
Aciclovir—Pruritus—Doxorubicin—prostate cancer	2.11e-05	0.000133	CcSEcCtD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.08e-05	0.000398	CbGpPWpGaD
Aciclovir—Vomiting—Epirubicin—prostate cancer	2.05e-05	0.00013	CcSEcCtD
Aciclovir—Diarrhoea—Doxorubicin—prostate cancer	2.04e-05	0.000129	CcSEcCtD
Aciclovir—Rash—Epirubicin—prostate cancer	2.03e-05	0.000128	CcSEcCtD
Aciclovir—Dermatitis—Epirubicin—prostate cancer	2.03e-05	0.000128	CcSEcCtD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.03e-05	0.000388	CbGpPWpGaD
Aciclovir—Headache—Epirubicin—prostate cancer	2.02e-05	0.000128	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—PIK3CG—prostate cancer	1.98e-05	0.000379	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.98e-05	0.000379	CbGpPWpGaD
Aciclovir—Dizziness—Doxorubicin—prostate cancer	1.97e-05	0.000125	CcSEcCtD
Aciclovir—SLC22A1—Metabolism—HPGD—prostate cancer	1.94e-05	0.000372	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—B4GALT4—prostate cancer	1.94e-05	0.000372	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—RXRA—prostate cancer	1.93e-05	0.000369	CbGpPWpGaD
Aciclovir—Nausea—Epirubicin—prostate cancer	1.92e-05	0.000121	CcSEcCtD
Aciclovir—Vomiting—Doxorubicin—prostate cancer	1.9e-05	0.00012	CcSEcCtD
Aciclovir—Rash—Doxorubicin—prostate cancer	1.88e-05	0.000119	CcSEcCtD
Aciclovir—Dermatitis—Doxorubicin—prostate cancer	1.88e-05	0.000119	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—INS—prostate cancer	1.88e-05	0.000359	CbGpPWpGaD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—MDM2—prostate cancer	1.87e-05	0.000359	CbGpPWpGaD
Aciclovir—Headache—Doxorubicin—prostate cancer	1.87e-05	0.000118	CcSEcCtD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.87e-05	0.000358	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CREBBP—prostate cancer	1.84e-05	0.000352	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—TNFRSF21—prostate cancer	1.83e-05	0.000349	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.78e-05	0.000341	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP7B1—prostate cancer	1.78e-05	0.00034	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—MTAP—prostate cancer	1.78e-05	0.00034	CbGpPWpGaD
Aciclovir—Nausea—Doxorubicin—prostate cancer	1.77e-05	0.000112	CcSEcCtD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—PPARA—prostate cancer	1.76e-05	0.000338	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PIK3CD—prostate cancer	1.74e-05	0.000333	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—SRD5A1—prostate cancer	1.73e-05	0.000331	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—SULT1E1—prostate cancer	1.73e-05	0.000331	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ACSL4—prostate cancer	1.65e-05	0.000316	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—HSD17B3—prostate cancer	1.65e-05	0.000316	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—NOS3—prostate cancer	1.64e-05	0.000315	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ARG2—prostate cancer	1.58e-05	0.000303	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—UMPS—prostate cancer	1.58e-05	0.000303	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PHGDH—prostate cancer	1.58e-05	0.000303	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.57e-05	0.000301	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—LDHB—prostate cancer	1.55e-05	0.000297	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP3A5—prostate cancer	1.52e-05	0.000292	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PIK3CB—prostate cancer	1.52e-05	0.000291	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PTGS2—prostate cancer	1.5e-05	0.000288	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—RXRA—prostate cancer	1.5e-05	0.000287	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	1.47e-05	0.000282	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTA3—prostate cancer	1.47e-05	0.000282	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—UCP3—prostate cancer	1.47e-05	0.000282	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PDHA1—prostate cancer	1.47e-05	0.000282	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—TCN2—prostate cancer	1.47e-05	0.000282	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—MDM2—prostate cancer	1.43e-05	0.000275	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—SLC22A3—prostate cancer	1.4e-05	0.000269	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—HSD3B1—prostate cancer	1.4e-05	0.000269	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.4e-05	0.000268	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—TBXAS1—prostate cancer	1.35e-05	0.000258	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTA4—prostate cancer	1.35e-05	0.000258	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PTEN—prostate cancer	1.31e-05	0.000251	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTA2—prostate cancer	1.31e-05	0.000251	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—SULT1A1—prostate cancer	1.3e-05	0.000248	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ABCG5—prostate cancer	1.3e-05	0.000248	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTA1—prostate cancer	1.27e-05	0.000242	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—NAT2—prostate cancer	1.25e-05	0.00024	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTO1—prostate cancer	1.25e-05	0.00024	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—EP300—prostate cancer	1.25e-05	0.00024	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—HSD3B2—prostate cancer	1.25e-05	0.00024	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PLCB2—prostate cancer	1.2e-05	0.00023	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP2C18—prostate cancer	1.2e-05	0.00023	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—LRP2—prostate cancer	1.2e-05	0.00023	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—P4HB—prostate cancer	1.18e-05	0.000225	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.17e-05	0.000224	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—PPARA—prostate cancer	1.14e-05	0.000219	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—SULT2A1—prostate cancer	1.12e-05	0.000213	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—MED12—prostate cancer	1.1e-05	0.00021	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GNG5—prostate cancer	1.09e-05	0.000208	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—NCOA3—prostate cancer	1.05e-05	0.000201	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—HPGDS—prostate cancer	1e-05	0.000191	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP2C19—prostate cancer	9.94e-06	0.00019	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTT1—prostate cancer	9.7e-06	0.000186	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ACHE—prostate cancer	9.7e-06	0.000186	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP2A6—prostate cancer	9.59e-06	0.000184	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—AKR1C3—prostate cancer	9.33e-06	0.000179	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PRKACB—prostate cancer	9.28e-06	0.000178	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PIK3CA—prostate cancer	9.25e-06	0.000177	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP17A1—prostate cancer	9.18e-06	0.000176	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	9.08e-06	0.000174	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—NCOA2—prostate cancer	8.75e-06	0.000168	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—SLC5A5—prostate cancer	8.35e-06	0.00016	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP2E1—prostate cancer	8.15e-06	0.000156	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—NQO1—prostate cancer	8.06e-06	0.000154	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—TH—prostate cancer	7.95e-06	0.000152	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP3A4—prostate cancer	7.86e-06	0.000151	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP1B1—prostate cancer	7.73e-06	0.000148	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—AKT1—prostate cancer	7.56e-06	0.000145	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GGT1—prostate cancer	7.49e-06	0.000143	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—NCOA1—prostate cancer	7.37e-06	0.000141	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP19A1—prostate cancer	7.27e-06	0.000139	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—RXRA—prostate cancer	7.01e-06	0.000134	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—COMT—prostate cancer	6.76e-06	0.000129	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTP1—prostate cancer	6.72e-06	0.000129	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ITPR1—prostate cancer	6.62e-06	0.000127	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—TYMS—prostate cancer	6.25e-06	0.00012	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTM1—prostate cancer	6.18e-06	0.000118	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—LPL—prostate cancer	6.06e-06	0.000116	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP1A1—prostate cancer	5.86e-06	0.000112	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ERCC2—prostate cancer	5.81e-06	0.000111	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—MTHFR—prostate cancer	5.46e-06	0.000105	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PPARA—prostate cancer	5.36e-06	0.000103	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CAV1—prostate cancer	5.04e-06	9.64e-05	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PIK3CG—prostate cancer	4.59e-06	8.78e-05	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—INS—prostate cancer	4.34e-06	8.32e-05	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CREBBP—prostate cancer	4.25e-06	8.14e-05	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PIK3CD—prostate cancer	4.03e-06	7.72e-05	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—NOS3—prostate cancer	3.81e-06	7.29e-05	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PIK3CB—prostate cancer	3.52e-06	6.73e-05	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PTGS2—prostate cancer	3.48e-06	6.67e-05	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PTEN—prostate cancer	3.04e-06	5.82e-05	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—EP300—prostate cancer	2.9e-06	5.55e-05	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PIK3CA—prostate cancer	2.14e-06	4.1e-05	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—AKT1—prostate cancer	1.75e-06	3.35e-05	CbGpPWpGaD
